Gainers
- Viveve Medical, Inc. (NASDAQ:VIVE) shares rose 22.7% to $5.41 in pre-market trading after falling 11.98% on Monday.
- Ocugen Inc (NASDAQ:OCGN) rose 16.5% to $3.32 in pre-market trading.
- SPI Energy Co., Ltd. (NASDAQ:SPI) rose 13.3% to $4.10 in pre-market trading after the company reported the sale of Sun Roof II and Sun Roof V solar projects in Italy.
- Geron Corporation (NASDAQ:GERN) rose 10.5% to $1.4702 in pre-market trading after the company disclosed that it has received an FDA Fast Track designation for Imetelstat for relapsed/refractory myelofibrosis.
- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) rose 7.4% to $5.80 in pre-market trading after the company disclosed that the Phase 3 PolarisDMD trial of edasalonexent in Duchenne Muscular Dystrophy has exceeded target enrollment.
- NewLink Genetics Corporation (NASDAQ:NLNK) rose 6.9% to $1.70 in pre-market trading after announcing it has entered a merger agreement with Lumos Pharma to form a biopharmaceutical company focused on developing therapies to treat rare diseases.
- Analog Devices, Inc. (NASDAQ:ADI) rose 5.9% to $118.33 in pre-market trading. KeyBanc upgraded Analog Devices from Sector Weight to Overweight and announced a $130 price target.
- Mallinckrodt plc (NYSE:MNK) shares rose 5.8% to $2.55 in pre-market trading after the company reported findings from its observational registry assessing Acthar Gel in MS relapse patients. The results were 'highly statistically significant' for all the efficacy endpoints.
- Synchronoss Technologies, Inc. (NASDAQ:SNCR) shares rose 5.4% to $5.69 in pre-market trading.
- Stitch Fix, Inc. (NASDAQ:SFIX) rose 4.4% to $20.10 in pre-market trading. Stitch Fix is expected to release quarterly earnings after the closing bell.
- Seadrill Limited (NYSE:SDRL) shares rose 3.8% to $2.18 in pre-market trading.
- Endeavour Silver Corp. (NYSE:EXK) rose 3.6% to $2.30 in pre-market trading after dropping 9.39% on Monday.
- National Vision Holdings, Inc. (NASDAQ:EYE) rose 3.6% to $24.93 in pre-market trading.
- LAIX Inc. (NYSE:LAIX) rose 3.5% to $4.45 in pre-market trading.
- Endo International plc (NASDAQ:ENDP) rose 3.4% to $3.32 in pre-market trading.
- United Natural Foods, Inc. (NYSE:UNFI) rose 3.3% to $11.90 in pre-market trading ahead of quarterly earnings.
- Sibanye Gold Limited (NYSE:SBGL) rose 3.3% to $5.58 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Genfit SA (NASDAQ:GNFT) shares fell 10.4% to $15.60 in pre-market trading after rising 8.88% on Monday.
- AnaptysBio, Inc. (NASDAQ:ANAB) fell 10% to $31.48 in pre-market trading after reporting topline data from interim analyst of GALLOP phase 2 clinical trial of ANB019 monotherapy in moderate-to-severe generalized pustular psoriasis.
- Reed's, Inc. (NASDAQ:REED) shares fell 9.2% to $1.18 after the company issued weak preliminary third-quarter sales guidance. The company also announced Chairman John Belo will serve as interim CEO.
- Hexcel Corporation (NYSE:HXL) fell 3.8% to $79.00 in pre-market trading.
- RELX PLC (NYSE:RELX) shares fell 3.7% to $22.84 in pre-market trading.
- Encana Corporation (NYSE:ECA) shares fell 3.1% to $4.46 in pre-market trading.
- Tata Motors Limited (NYSE:TTM) fell 3% to $8.14 in pre-market trading.
- U.S. Silica Holdings, Inc. (NYSE:SLCA) fell 2.5% to $9.32 in the pre-market trading session.
- Galapagos NV (NASDAQ:GLPG) fell 2.2% to $149.41 in the pre-market trading session.
ANABAnaptysBio Inc
$45.78-%
EXKEndeavour Silver Corp
$9.430.22%
EYENational Vision Holdings Inc
$28.89-1.23%
GERNGeron Corp
$1.37-1.39%
GLPGGalapagos NV
$32.57-%
HXLHexcel Corp
$72.77-4.78%
OCGNOcugen Inc
$1.27-2.31%
REEDReed's Inc
Not Available-%
RELXRELX PLC
$40.28-%
SDRLSeadrill Ltd
$33.300.91%
SFIXStitch Fix Inc
$5.60-0.36%
SNCRSynchronoss Technologies Inc
$8.55-0.23%
UNFIUnited Natural Foods Inc
$32.49-0.06%
VIVEViveve Medical Inc
$0.000001-100.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
